Investment giants BlackRock and The Vanguard Group stand to benefit from their ownership stakes in most of the corporations that imposed COVID vaccine mandates, and in some of the technology firms developing vaccine passports.
After the U.S. Supreme Court last month froze the Biden administration’s COVID-19 vaccine mandate for large private employers, some companies — including Boeing, General Electric and Starbucks — dropped plans to implement the mandate.
Others, based on guidance issued in 2020 by the Equal Employment Opportunity Commission, left the mandates in place.
Most of the large employers that opted to mandate COVID vaccines for their employees, even though the Supreme Court ruled they didn’t have to, have something in common: BlackRock and The Vanguard Group have ownership stakes in them.
BlackRock and Vanguard, two of the world’s “Big Three” asset managers, also are among the top three shareholders of COVID vaccine makers Pfizer, Moderna and Johnson & Johnson — which means the two investment giants stand to benefit from these companies’ soaring profits and the resulting rise in those companies’ stock prices.
BlackRock and Vanguard don’t just benefit from sales of COVID vaccines. As it turns out, they also have ownership stakes in technology companies developing vaccine passports and digital wallets.